R. Miyazaki et al., ACROMEGALIC GIGANTISM WITH LOW SERUM LEVEL OF GROWTH-HORMONE AND ELEVATED SERUM INSULIN-LIKE GROWTH-FACTOR-I, Internal medicine, 34(3), 1995, pp. 183-187
In a case of acromegalic gigantism with hyperprolactinemia is reported
, the basal serum growth hormone (GH) levels ranged from 1.2 to 1.9 ng
/ml. Serum GH response to either insulin-induced hypoglycemia or GH-re
leasing hormone was blunted. Frequent blood sampling showed non-pulsat
ile GH secretion. Serum prolactin and insulin-like growth factor-I (IG
F-I) levels were elevated. After unsuccessful surgery, bromocriptine t
reatment normalized serum prolactin without affecting serum GH and IGF
-I levels. Combined administration of octreotide with bromocriptine re
duced serum GH and IGF-I levels. In this case, non-pulsatile GH secret
ion and enhanced tissue sensitivity to GH may induce hypersecretion of
IGF-I and cause clinical acromegalic gigantism.